Description

BioFosfina (Original) Solution

BioFosfina (Original) Solution is a therapeutic injectable supplement developed to support recovery and improve cellular energy metabolism. Known for its safety profile and tolerability, BioFosfina is commonly used in managing fatigue, neuropathy, and recovery post-surgery. Its formulation enhances mitochondrial function, supports nerve conduction, and aids in systemic regeneration.

Composition

Each 1 ml of BioFosfina (Original) Solution contains:

• Biofosfina (100 mg): A proprietary phosphoric compound supporting cellular metabolism
• Sodium chloride: Maintains isotonicity
• Benzyl alcohol: Preservative
• Water for injection

Description

BioFosfina is a sterile, colorless injectable solution, presented in ampoules for intramuscular or slow intravenous administration. It is primarily utilized as a supportive agent in conditions characterized by cellular energy deficiency or increased metabolic demand.

Pharmacological Properties

The active compound in BioFosfina plays a critical role in ATP regeneration and the Krebs cycle, contributing to enhanced cellular respiration and energy production. It supports peripheral nerve regeneration and improves neuromuscular transmission. This makes it effective in both neurological and physical fatigue conditions.

Indications

BioFosfina is indicated in the following conditions:

• Chronic fatigue syndrome
• Peripheral neuropathy (diabetic, post-viral, idiopathic)
• Postoperative recovery
• Asthenia associated with chronic disease
• General metabolic support in convalescence

Dosage and Administration

• Standard adult dose: 1 ampoule per day via intramuscular injection or slow intravenous infusion
• Duration: Typically 5 to 10 days, depending on clinical condition
• Dosage may be adjusted based on age, weight, and response to therapy
• Only a licensed healthcare provider should administer this product

Contraindications

• Hypersensitivity to any ingredient of the solution
• Severe renal insufficiency
• Metabolic acidosis
• Patients with known phosphate metabolism disorders

Side Effects

Most patients tolerate BioFosfina well. However, possible adverse reactions include:

• Mild nausea or gastrointestinal discomfort
• Headache
• Local pain, redness, or swelling at injection site
• Rare allergic reactions (rash, pruritus)

Precautions

• Use cautiously in patients with renal impairment or electrolyte imbalance
• Monitor serum phosphate levels in prolonged therapy
• Inform physician of any pre-existing metabolic or cardiovascular conditions

Interactions

• Concomitant use with calcium-containing solutions may lead to precipitation
• Potential interaction with other phosphate or potassium supplements
• Inform healthcare provider of all concurrent medications and supplements

Overdose

Overdose may result in symptoms such as:

• Severe gastrointestinal upset
• Dizziness or confusion
• Electrolyte disturbances

In case of suspected overdose, initiate supportive and symptomatic care immediately. Monitor renal function and serum electrolytes.

Storage

• Store at 15–25°C (59–77°F)
• Protect from light and moisture
• Do not freeze
• Keep out of reach of children and pets

Additional Information

BioFosfina is a prescription medication and must only be used under medical supervision. Ensure correct dilution and administration technique. Periodic monitoring may be necessary in long-term treatment courses. Report any unusual or persistent symptoms to a healthcare provider promptly.

Scientific Reference

• Lanza et al. – Phosphate compounds in fatigue and nerve repair